Lihe Dai
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Surgery 5
- Bladder and Urothelial Cancer Treatments 4
-
- Peroxisome Proliferator-Activated Receptors 1
- Genomics and Phylogenetic Studies 1
- Co-authors
- Zhensheng Zhang (5 shared papers)Chuanliang Xu (7 shared papers)Shuxiong Zeng (6 shared papers)Yinghao Sun (4 shared papers)Jun Yang (3 shared papers)Anwei Liu (2 shared papers)Huiqing Wang (3 shared papers)Fei Liu (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Journal of Translational Medicine (1 paper)Molecular Biology Reports (1 paper)Gene (1 paper)iScience (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Lihe Dai
11 papers receiving 193 citations
Peers
Comparison fields: 5 of 41
- Cancer Research 33
- Surgery 53
- Cell Biology 20
- Molecular Biology 81
- Oncology 22
Countries citing papers authored by Lihe Dai
This map shows the geographic impact of Lihe Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihe Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihe Dai more than expected).
Fields of papers citing papers by Lihe Dai
This network shows the impact of papers produced by Lihe Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihe Dai. The network helps show where Lihe Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Lihe Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 42 | |
| 2 | 2018 | 39 | |
| 3 | 2020 | 36 | |
| 4 | 2023 | 22 | |
| 5 | 2016 | 19 | |
| 6 | 2019 | 12 | |
| 7 | 2020 | 11 | |
| 8 | [Sequence and polymorphism analysis of porcine hormone-sensitive lipase gene 5'-UTR and exon I]. | 2005 | 7 |
| 9 | 2016 | 4 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Lihe Dai
Lihe Dai is a scholar working on Surgery, Molecular Biology, Cell Biology, Oncology and Physiology, having authored 13 papers that have together received 196 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Microtubule and mitosis dynamics (1 paper), Sperm and Testicular Function (1 paper), Peptidase Inhibition and Analysis (1 paper), Lipid metabolism and biosynthesis (1 paper) and Genomics and Phylogenetic Studies (1 paper). The work is most often cited by research in Cancer Research (33 citations), Surgery (53 citations), Cell Biology (20 citations), Molecular Biology (81 citations) and Oncology (22 citations). Lihe Dai has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Zhensheng Zhang, Chuanliang Xu, Shuxiong Zeng, Yinghao Sun, Jun Yang, Anwei Liu, Huiqing Wang, Fei Liu, Xiaowen Yu and Qiao Xiong. Their work appears in journals such as Clinical Cancer Research, Journal of Translational Medicine, Molecular Biology Reports, Gene and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.